Pathogenesis of tissue injury in MS lesions

Journal of Neuroimmunology

Volumn 98, Issue 1, 1999, Pages 49-56

  Trapp, Bruce D ^a   Bö, Lars ^a   Mörk, Sverre ^a   Chang, Ansi ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Axonal degeneration; Microglia; Multiple sclerosis; Nitric oxide

Indexed keywords

APOPTOSIS; CONFERENCE PAPER; DEMYELINATION; DISABILITY; DISEASE COURSE; HUMAN; MICROGLIA; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; TISSUE INJURY;

ASTROCYTES; AXONS; DEMYELINATING DISEASES; HUMANS; MICROGLIA; MULTIPLE SCLEROSIS;

EID: 0033022516     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00081-8     Document Type: Conference Paper

References (45)

1. Anzini P., Neuberg D.H.-H., Schachner M., Nelles E., Willecke K., Zielasek J., Toyka K.V., Suter U., Martini R. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 17:1997;4545-4551.
2. Bagasra O., Michaels F.H., Zheng Y.M., Bobroski L.E., Spitsin S.V., Fu Z.F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;12041-12045.
3. Bö L., Dawson T.M., Wesselingh S., Mörk S., Choi S., Kong P.A., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
4. Bö L., Mörk S., Kong P.A., Nyland H., Pardo C.A., Trapp B.D. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J. Neuroimmunol. 51:1994;135-146.
5. Bonetti B., Raine C.S. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:1997;74-84.
6. NTR: a receptor after all. Science. 272:1996;506-507.
7. Boyle E.A., McGeer P.L. Cellular immune response in multiple sclerosis. Am. J. Pathol. 137:1990;575-584.
8. Bradley W.G. Recent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies. Muscle Nerve. 10:1998;490-502.
9. Cannella B., Raine C.S. Adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:1995;424-435.
10. Casaccia-Bonnefil P., Carter B.D., Dobrowsky R.T., Chao M.V. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 383:1996;716-719.
11. Charcot M. Histologie de la sclèrose en plaques. Gaz Hosp. 141:1868;5545-5578.
12. Davie C.A., Barker G.J., Webb S., Tofts P.S., Thompson A.J., Harding A.E., McDonald W.I., Miller D.H. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain. 118:1995;1583-1592.
13. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing whtie matter in multiple sclerosis J. Neurol. Neurosurg. Psychiatry. 63:1997;736-742.
14. De Stefano N., Matthews P.M., Antel J.P., Preul M., Francis G., Arnold D.L. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann. Neurol. 38:1995;901-909.
15. deWaegh S.M., Lee V.M.-Y., Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell. 68:1992;451-463.
16. Dowling P., Husar W., Menonna J., Donnenfeld H., Cook S., Sidhu M. Cell death and birth in multiple sclerosis brain. J. Neurol. Sci. 149:1997;1-11.
17. Dowling P., Raval S., Husar W., Casaccia-Ponnefil P., Chao M., Cook S., Blumberg B. Expression of the p75 neurotrophin receptor in oligodendrocytes in multiple sclerosis brain. Neurology. 48:1997;A25. (Abstract).
18. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain. 120:1997;393-399.
19. Fu L., Matthews P.M., De Stafano N., Worsley K.J., Narayanan S., Francis G.S., Antel J.P., Wolfson C., Arnold D.L. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain. 121:1998;103-113.
20. Genain C.P., Nguyen M.H., Letvin N.L., Pearl R., Davis R.L., Adelman M., Lees M.B., Linington C., Hauser S.L. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96:1995;2966-2974.
21. o gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell. 71:1992;565-576.
22. Greenfield J.G., King L.S. Observations on the histopathology of the cerebral lesions in disseminated sclerosis. Brain. 59:1936;445-458.
23. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., Nave K.-A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science. 280:1998;1610-1613.
24. Heide A.C., Kraft G.H., Slimp J.C., Gardner J.C., Posse S., Serafini S., Bowen J.D., Richards T.L. Cerebral N-acetylaspartate is low in patients with multiple sclerosis and abnormal visual evoked potentials. Am. J. Neuroradiol. 19:1998;1047-1054.
25. Hu S., Sheng W.S., Peterson P.K., Chao C.C. Differential regulation by cytokines of human astrocyte nitric oxide production. Glia. 15:1995;491-494.
26. Koo E.H., Sisodia S.S., Archer D.R., Martin L.J., Weidemann A., Beyreuther K., Fischer P., Masters C.L., Price D.L. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. U.S.A. 87:1990;1561-1565.
27. Ladiwala U., Lachance C., Simoneau S.J.J., Bhakar A., Barker P.A., Antel J.P. p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J. Neurosci. 18:1998;1297-1304.
28. Lassmann H., Raine C.S., Antel J., Prineas J.W. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J. Neuroimmunol. 86:1998;213-217.
29. Lee S.C., Dickson D.W., Liu W., Brosnan C.F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J. Neuroimmunol. 46:1993;19-24.
30. Lloyd K.G. CNS compensation to dopamine neuron loss in Parkinson's disease. Adv. Exp. Med. Biol. 90:1977;255-266.
31. Losseff N.A., Miller D.H. Measures of brain and spinal cord atrophy in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 64:1998;S102-S105.
32. Losseff N.A., Wang L., Lai H.M., Yoo D.S., Gawne-Cain M.L., McDonald W.I., Miller D.H., Thompson A.J. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain. 119:1996;2009-2019.
33. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
34. Oleszak E.L., Zaczynska E., Bhattacharjee M., Butunoi C., Legido A., Katsetos C.D. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin. Diagn. Lab. Immunol. 5:1998;438-445.
35. Prineas, J.W., McDonald, W.I., 1997. Demyelinating diseases. In: Graham, D.I., Lantos, P.L. (Eds.), Greenfield's Neuropathology. Oxford Univ. Press, New York, 1997, pp. 813-896.
36. Putnam T.J. Studies in multiple sclerosis. Arch. Neurol. Psychol. 35:1936;1289-1308.
37. Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
38. Simon J.H., Schiffer R.B., Rudick R.A., Herndon R.M. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging. Am. J. Neuroradiol. 8:1987;599.
39. Sriram S., Rodriguez M. Indictment of the microglia as the villain in multiple sclerosis (review). Neurology. 48:1997;464-470.
40. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mörk S., Bö L. Axonal transection in multiple sclerosis lesions. N. Engl. J. Med. 338:1998;278-285.
41. Trapp B.D., Ransohoff R.M., Fisher E., Rudick R.A. Neurodegeneration in multiple sclerosis: relationship to neurological disability. The Neuroscientist. 5:1999;48-57.
42. Verdi J.M., Birren S.J., Ibanez C.F., Persson H., Kaplan D.R., Benedetti M., Chao M.V., Anderson D.J. p75(LNGFR) regulates trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron. 12:1994;733-745.
43. Waxman S.G. Demyelinating diseases - new pathological insights, new therapeutic targets. N. Engl. J. Med. 338:1998;323-325.
44. Yin X., Crawford T.O., Griffin J.W., Tu P.-H., Lee V.M.-Y., Li C., Roder J., Trapp B.D. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 18:1998;1953-1962.
45. Yoon S.O., Casaccia-Bonnefil P., Carter B., Chao M.V. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J. Neurosci. 18:1998;3273-3281.